Therapeutic Biomarkers in Metastatic Castration-Resistant Prostate Cancer: Does the State Matter?

Investigators outline precision medicine in metastatic cCRPC, zooming in on the role of circulating tumor DNA, to identify genomic biomarkers that may be used to tailor molecularly targeted therapies.